abstract |
The invention described herein relates to novel genes and their encoded proteins, termed M utants A ssociated with R esistance to STI-571 (e.g.,T315I Bcr-Abl), and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express MARS. The invention further provides methods for identifying molecules that bind to and/or modulate the functional activity of MARS. |